Radiopharm Theranostics L...

NASDAQ: RADX · Real-Time Price · USD
4.78
-0.23 (-4.69%)
At close: Aug 15, 2025, 2:14 PM
5.12
7.11%
After-hours: Aug 15, 2025, 05:49 PM EDT

Radiopharm Theranostics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
Net Income
n/a n/a n/a
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
n/a n/a n/a
Other Non-Cash Items
n/a n/a n/a
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
n/a n/a n/a
Operating Cash Flow
n/a n/a n/a
Capital Expenditures
n/a -1.53M -28.34M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a -1.49M -28.37M
Investing Cash Flow
n/a -1.53M -28.37M
Debt Repayment
2.2M n/a -59K
Common Stock Repurchased
-1.53M -854.76K -4.83M
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-437K n/a n/a
Financial Cash Flow
29.88M 9.22M 65.11M
Net Cash Flow
6.88M -15.28M 26.95M
Free Cash Flow
-22.98M -24.73M -38.25M